Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lyra Therapeutics (LYRA) Tax Rate (2023 - 2025)

Lyra Therapeutics (LYRA) has disclosed Tax Rate for 3 consecutive years, with 0.05% as the latest value for Q3 2025.

  • On a quarterly basis, Tax Rate rose 1.0% to 0.05% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.05%, a 1.0% increase, with the full-year FY2024 number at 0.04%, up 5.0% from a year prior.
  • Tax Rate was 0.05% for Q3 2025 at Lyra Therapeutics, down from 0.03% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 0.02% in Q2 2024 to a low of 0.11% in Q4 2023.
  • A 3-year average of 0.06% and a median of 0.06% in 2024 define the central range for Tax Rate.
  • Peak YoY movement for Tax Rate: increased 6bps in 2024, then changed 0bps in 2025.
  • Lyra Therapeutics' Tax Rate stood at 0.11% in 2023, then soared by 51bps to 0.05% in 2024, then increased by 8bps to 0.05% in 2025.
  • Per Business Quant, the three most recent readings for LYRA's Tax Rate are 0.05% (Q3 2025), 0.03% (Q2 2025), and 0.05% (Q1 2025).